Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash, according to an Abbott press release.

Abbott to Acquire Solvay Pharmaceuticals for $6.6 Billion

Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more...

Week of Sept. 21, 2009: AstraZeneca and Nektar Sign License Agreement; Eli Lilly Names President of Lilly USA, More...

The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5, 2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active pharmaceutical ingredients (APIs).

Bayer Receives Warning Letter for Alleged Deviations

Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more...

Week of Sept. 14, 2009: Evotec and Biogen Idec Form Pact; Marijn Dekkers Leaves Thermo Fisher Scientific for Bayer; More...

Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...

Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes; More...

The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week.

USP to Develop Standards with Mexican Commission

Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...

Week of Aug. 31, 2009: Roche Purchases Lonza Facility; SCOLR Pharma Names CEO; More...

Brief pharmaceutical news items for September 2009.

Pharma Capsules

Michelle Hoffman, editorial director of Pharmaceutical Technology.

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.

Quality by Enforcement

An outstanding new book reviews alternative solvents with an eye to sustainable pharmaceutical processes.

Ingredients